Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
about
Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic ratsFundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's diseaseNeuroinflammation in Alzheimer's diseaseResveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cellsA network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of actionAlkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide.Attenuating effect of standardized fruit extract of Punica granatum L in rat model of tibial and sural nerve transection induced neuropathic pain.Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity.Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia.P2Y13 receptor-mediated rapid increase in intracellular calcium induced by ADP in cultured dorsal spinal cord microglia.Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytesGalectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment.Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN.Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells.Lipopolysaccharide animal models for Parkinson's disease.Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?Anti-neuroinflammatory agents for the treatment of Alzheimer's disease.Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage.PPARγ and PGC-1α as therapeutic targets in Parkinson's.Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.Systemic and local anti-nociceptive effects of simvastatin in the rat formalin assay: Role of peroxisome proliferator-activated receptor γ and nitric oxide.(+)-Catechin Attenuates NF-κB Activation Through Regulation of Akt, MAPK, and AMPK Signaling Pathways in LPS-Induced BV-2 Microglial Cells.Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells.Vespa tropica venom suppresses lipopolysaccharide-mediated secretion of pro-inflammatory cyto-chemokines by abrogating nuclear factor-κ B activation in microglia.Suppression of LPS-induced inflammatory responses by inflexanin B in BV2 microglial cells.Emodin ameliorates high-glucose induced mesangial p38 over-activation and hypocontractility via activation of PPARgamma.Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury.The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function.Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFαBerberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways.Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.Rosiglitazone protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity through inhibition of microglia activation.Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.
P2860
Q26747585-A1990B24-47FB-45D8-BF86-58354D4773F3Q26748713-938FFEAA-107C-4FE9-98A1-D10BBB5B8900Q27004226-38DDF40C-F111-485E-B319-069AD4C411A0Q28483244-5CE2A075-94B9-4A34-9DDF-8873BE1AB959Q28538646-ADA0CE53-F037-48AC-BAC1-C1EF9AF8F4A3Q30371352-4C3AB9CD-5B56-4F32-853B-78FEC0B119F1Q31150361-F52E32C6-56A3-42F8-B1C6-50C29A2C1A77Q33575523-3767C33C-0489-4B49-825A-8BA6EE1F935DQ34077007-32709EA4-706C-4446-9F1F-E2E18D6D07ADQ34720059-5AC3A98B-BF86-4FA9-B228-0EE7E847372BQ35237806-4BC27AFD-F870-45A2-AE47-AFC149676AFDQ35612987-37AD4DA4-6C57-47F5-948A-3CC15632440CQ36191881-B142BACA-7055-43E1-B35A-FA9137D95A87Q36835199-B5A50356-517C-4836-9042-73C231F8EBA2Q37640235-37853D06-0BBE-40E8-92D0-D4A6CCA5131BQ37677252-61E0B7BF-1CD6-4885-BB60-907F83FC606DQ37689883-BF3D404F-B3FD-4CA2-AD30-F161C01A5222Q37727280-27362D44-F1BA-4E5E-9BE9-7BB4C7AC4C84Q37878278-B1FAF715-A1F5-4F82-A2E0-2A4ED08E5E05Q37878285-DF218A53-F33F-4B7C-895E-659C88049969Q38032481-893B087E-12B4-4E02-B0E9-698802A5B417Q38136313-605ADEA3-8860-46BE-9401-A8558D7062C6Q38170066-FFBE3746-9266-4154-9242-44643FD64DDAQ38227702-F79B47E2-50E6-49E3-9D27-35A8D11703EAQ38645013-F031A7A2-FFEE-46FE-BAC8-3FE44F2A69D6Q38832154-540202A7-0562-402E-9E7D-B947D36432E5Q38847732-A4DB8107-35C0-4E08-9777-253C4E0476C4Q38975152-E273AC81-473D-418E-AFBA-D0D32DB2D3DCQ39000204-06141A51-65E4-4EAB-875C-C4DDB5460305Q39185717-31E18D0E-7899-4BF7-874E-E15066E274A1Q39845676-EC612785-5E80-45BF-B97D-DCDD3BC1BC59Q41148387-20F4EAF6-E049-4B89-96CF-AD88A367929FQ41312221-E663EF5A-92DD-421E-A6A9-4714FACCC514Q41886732-1C3D31E8-C75D-47AA-AF8C-8ACAAAA91B34Q42065117-D7A1875C-DBC6-4F3C-9955-3AA5E10C3B3EQ42608624-8F5106F8-57F3-4B75-BF07-EDB80ED3F3CFQ44888109-2E90B9E4-7618-4D46-B7E4-792EAB7A1260Q47687993-538A6E9A-F1EC-4FB7-8750-496831D8273AQ48554941-75D9B4C5-B27F-451F-897C-BEF31BEDDD08Q51604439-DB090543-44BC-43AC-B677-B434EFEF0D6B
P2860
Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pioglitazone inhibition of lip ...... of p38 MAP kinase and PI3K/Akt
@ast
Pioglitazone inhibition of lip ...... of p38 MAP kinase and PI3K/Akt
@en
type
label
Pioglitazone inhibition of lip ...... of p38 MAP kinase and PI3K/Akt
@ast
Pioglitazone inhibition of lip ...... of p38 MAP kinase and PI3K/Akt
@en
prefLabel
Pioglitazone inhibition of lip ...... of p38 MAP kinase and PI3K/Akt
@ast
Pioglitazone inhibition of lip ...... of p38 MAP kinase and PI3K/Akt
@en
P2093
P2860
P356
P1476
Pioglitazone inhibition of lip ...... of p38 MAP kinase and PI3K/Akt
@en
P2093
Randy Lee Hunter
P2860
P2888
P356
10.1186/1742-2094-5-4
P50
P577
2008-01-18T00:00:00Z
P5875
P6179
1006225174